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Abstract 
Candida albicans is a diploid fungus that undergoes a morphological transition be-
tween budding yeast, hyphal, and pseudohyphal forms. The morphological transi-
tion is strongly correlated with virulence and is regulated in part by quorum sensing. 
Candida albicans produces and secretes farnesol that regulates the yeast to myce-
lia morphological transition. Mutants that fail to synthesize or respond to farne-
sol could be locked in the filamentous mode. To test this hypothesis, a collection of 
C. albicans mutants were isolated that have altered colony morphologies indicative 
of the presence of hyphal cells under environmental conditions where C. albicans 
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normally grows only as yeasts. All mutants were characterized for their ability to 
respond to farnesol. Of these, 95.9% fully or partially reverted to wildtype mor-
phology on yeast malt (YM) agar plates supplemented with farnesol. All mutants 
that respond to farnesol regained their hyphal morphology when restreaked on 
YM plates without farnesol. The observation that farnesol remedial mutants are so 
common (95.9%) relative to mutants that fail to respond to farnesol (4.1%) sug-
gests that farnesol activates and (or) induces a pathway that can override many of 
the morphogenesis defects in these mutants. Additionally, 9 mutants chosen at ran-
dom were screened for farnesol production. Two mutants failed to produce detect-
able levels of farnesol. 
Keywords: farnesol-remedial mutants, farnesol-sensing mutants, farnesol-synthe-
sis mutants, quorum sensing, Candida albicans, morphological transition. 
Résumé 
Candida albicans est un champignon diploïde qui subit une transition morphologique 
entre les levures en herbe, les hyphes et les formes pseudohyphales. La transition 
morphologique est fortement corrélée à la virulence et est régulée en partie par la 
détection du quorum. Candida albicans produit et sécrète du farnésol qui régule la 
transition morphologique levure-mycélium. Les mutants qui ne parviennent pas 
à synthétiser ou à répondre au farnésol pourraient être verrouillés en mode fila-
menteux. Pour tester cette hypothèse, une collection de mutants de C. albicans a 
été isolée qui ont modifié les morphologies des colonies, indiquant la présence de 
cellules hyphales dans des conditions environnementales où C. albicans ne pousse 
normalement que sous forme de levures. Tous les mutants ont été caractérisés pour 
leur capacité à répondre au farnésol. Parmi ceux-ci, 95,9% sont entièrement ou par-
tiellement revenus à la morphologie de type sauvage sur des plaques de gélose au 
levure de malt (YM) complétées par du farnésol. Tous les mutants qui répondent 
au farnésol ont retrouvé leur morphologie hyphale lorsqu’ils ont été recréés sur 
des plaques YM sans farnésol. L’observation selon laquelle les mutants curatifs du 
farnésol sont si communs (95,9%) par rapport aux mutants qui ne répondent pas 
au farnésol (4,1%) suggère que le farnésol s’active et (ou) induit une voie qui peut 
supplanter bon nombre des défauts de morphogenèse de ces mutants. De plus, 9 
mutants choisis au hasard ont été testés pour la production de farnésol. Deux mu-
tants n’ont pas réussi à produire des niveaux détectables de farnésol.
Mots-clés: mutants réparateurs du farnésol, mutants sensibles au farnésol, mu-
tants de synthèse du farnésol, détection du quorum, Candida albicans, transition 
morphologique.
Introduction 
The dimorphic fungus Candida albicans is the causative agent of vag-
inal yeast infections, oral thrush, and a series of other fungal mala-
dies. Normally, C. albicans is a member of the intestinal tract flora. 
It becomes a pathogen when conditions permit it to adhere, colonize, 
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and invade epithelial tissues. Premature infants, surgical patients, and 
cancer patients receiving immunosuppressive chemotherapy are es-
pecially at risk for developing candidiasis. This is a serious disease, 
as 30%–38% of the patients with candidiasis die (Viudes et al. 2002; 
Gudlaugsson et al. 2003). 
Candida albicans undergoes a morphological transition between 
a budding yeast form and the hyphal and pseudohyphal forms. The 
morphological transition is strongly correlated with virulence because 
yeast- and mycelia-only mutants are non-infective in a mouse model 
(Lo et al. 1997; Bendel et al. 2003). The mycelial and yeast forms are 
probably important for colonization and spread, respectively. This 
morphological transition is regulated by many environmental and 
chemical signals including temperature and quorum sensing (Hornby 
et al. 2001). With regard to temperature, C. albicans generally grows 
as yeasts at ≤30 °C and as filaments at 37 °C. With regards to quo-
rum sensing, C. albicans produces and secretes an extracellular mole-
cule, farnesol, which regulates the morphological transition (Hornby 
et al. 2001). During growth at 37 °C, farnesol accumulates, hyphal de-
velopment is inhibited, and the cells grow instead as budding yeasts. 
Exogenous farnesol also blocks the yeast to filamentous conversion 
in response to most, if not all, environmental and chemical inducers 
(Mosel et al. 2005). Because the morphological transition is critical 
for pathogenicity, it is important to understand how it is regulated by 
farnesol. In particular, we ultimately want to know how many farne-
sol-binding targets exist, and how farnesol binding leads to an altered 
cell morphology. 
Mutants that fail to synthesize or respond to farnesol should be 
unable to block the yeast to mycelia conversion and thus would be 
more likely to grow in the filamentous mode. They may even lose 
the ability to grow in the yeast form. To test this hypothesis, we iso-
lated a collection of C. albicans mutants that had a hyphal or pseudo-
hyphal morphology under environmental conditions (28 °C) where 
C. albicans normally grows as yeasts and characterized the ability of 
these mutants to respond to farnesol. We found that farnesol-respon-
sive mutants existed and were common. A subset of the mutants was 
also tested for their ability to synthesize farnesol. Two mutants did 
not synthesize detectable amounts of farnesol. The analysis of these 
mutants is an important first step in understanding the role farnesol 
plays in regulation of the C. albicans morphological transition. 
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Materials and methods 
Strains and media 
Candida albicans A72 (kindly provided by Patrick A. Sullivan, Uni-
versity of Otago, New Zealand) was originally isolated from a patient 
by Dr. Antonio Cassone (Rome, Italy). It does not have any auxotro-
phic markers and it is available from the American Type Culture Col-
lection (Rockville, Md.) as strain MYA2430. Candida albicans CAI-4 
(ura3::imm434/ura3::imm434; Fonzi and Irwin 1993) was obtained 
from Gerald Fink at the Whitehead Institute for Biomedical Research 
(Cambridge, Mass.). CAI-4 is derived from SC5314, a clinical isolate, 
by gene replacement using homologous recombination to replace both 
copies of its URA3 gene (Fonzi and Irwin 1993). CAI-4 also has a de-
letion of the 3′ half of IRO1 and, thus, is partially defective in iron up-
take and utilization (Garcia et al. 2001). A72 and CAI-4 produce spon-
taneous odd colonies at a frequency of about 1 in 10,000 (0.01%). 
However, none of these spontaneous odd colonies were stable; they all 
changed colony morphology within 3–4 transfers. Thus, stability be-
yond 3–4 transfers was the criterion we used to select stable altered 
colony morphologies. These cells are either mutants or they have an 
exceptionally stable colony-type switch. For simplicity in this paper, 
we use the term “mutants” to describe these cells. A72 and CAI-4 were 
used in both mutagenesis protocols described below. 
Strains were maintained on yeast malt (YM; Difco Laboratories, 
Sparks, Md.; Tucker, Ga.; Barret et al. 1990) or YEPD (1% w/v yeast 
extract, 2% w/v bacto peptone, 2% w/v glucose) agar stored at 4 °C. 
Other media used were yeast nitrogen base (YNB; Difco) supplemented 
with 2.5 mmol/L N-acetylglucosamine, a defined glucose–phosphate–
proline medium with 2.5 mmol/L N-acetylglucosamine (mGPP), and a 
modified glucose–salts–biotin (mGSB) medium. The mGPP (Hornby et 
al. 2001) contained the following on a per liter basis: 20 g glucose, 1.15 
g l-proline, 0.55 g N–acetylglucosamine, 4 g KH2PO4, 3.2 g Na2 HPO4, 
0.5 g MgSO4·7H2O, 1 mg CuSO4·5H2O, 1 mg ZnSO4·7H2O, 1 mg MnCl2, 1 
mg FeSO4, 20 μg biotin, 200 μg pyridoxine·HCl, 200 mg thiamine·HCl 
(pH 6.5). The glucose (20% w/v) and l-proline (100 mmol/L) were 
autoclaved separately and added aseptically, as were the filter-ster-
ilized vitamins (1000-fold stock prepared in 20% v/v ethanol). The 
mGSB (Hornby et al. 2001) medium contained the following on a per 
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liter basis: 1 g (NH4)2SO4, 2 g KH2PO4, 50 mg MgSO4·7H2O, 50 mg 
CaCl2·2H2O, and 1 g peptone. After autoclaving, 30 mL of 50% w/v 
glucose and 0.4 mL of the mGPP vitamin stock were added aseptically. 
Mutagenesis and isolation of mutants 
Candida albicans cells with a stable altered colony morphology were 
selected from cultures treated with 2 mutagenesis protocols. The first 
protocol consisted of treatment with ethylmethane sulfonate (EMS), 
to stimulate a high number of transitions at GC sites (Kohalmi and 
Kunz 1988), followed by ultraviolet (UV) irradiation. Candida albi-
cans is diploid and UV irradiation was used to stimulate mitotic re-
combination, thus making recovery of recessive mutations possible 
(Kakar et al. 1983). The second protocol consisted of treatment with 
EMS followed by nitrous acid. Nitrous acid stimulates transitions at 
and GC sites. In both mutagenesis schemes, A72 and CAI-4 were mu-
tagenized to 50% viability. 
Candida albicans A72 cells from a 5- to 7-day-old YM agar plate 
were transferred to 50 mL mGSB medium and grown at 30 °C for 30 
h to stationary phase with shaking at 200 r/min. The cells were re-
covered by centrifugation for 10 min at 4350g (6000 rpm in a Beck-
man JA-20 rotor) and washed 3 times with 10 mL of 0.05 mol/L potas-
sium phosphate buffer (pH 6.5). The washed cells were resuspended 
in 10 mL of this buffer. A “time 0” cell titer was determined by remov-
ing a 0.1 mL sample that was diluted and plated onto YM agar to give 
150–200 colonies per plate. Two hundred fifty microliters of EMS was 
added to the remaining 9.9 mL cell suspension. This mixture was in-
cubated for 40 min at room temperature with gentle mixing every 5 
min. EMS was then neutralized by adding 10 mL of 6% w/v sodium 
thiosulfate and incubating for 20 min at room temperature. The cells 
were washed once with 10 mL of 6% w/v sodium thiosulfate and twice 
with 10 mL of 0.05 mol/L potassium phosphate buffer (pH 6.5). The 
cells were resuspended in 10 mL of 0.05 mol/L potassium phosphate 
buffer (pH 6.5), diluted (by a factor of 10–4 and 10–5), and plated on 
YM agar. The plates were subjected to 50 J of ultraviolet light C (UV-
C) (2.5 J/s for 20 s) and incubated at 30 °C until colonies were visible. 
Nitrous acid mutagenesis was basically identical to that used by Ka-
kar et al. (1983). Cells were grown and collected via centrifugation as 
described for EMS mutagenesis. However, the cells were washed and 
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resuspended in 10 mL of 0.1 mol/L sodium acetate buffer (pH 4.5) in-
stead of in the phosphate buffer used for EMS. A time 0 titer was ob-
tained in an identical fashion as for EMS mutagenesis. The remaining 
9.9 mL of cell suspension was centrifuged and resuspended in 9.9 mL 
of filter-sterilized 0.1 mol/L sodium acetate buffer (pH 4.5) contain-
ing 0.06 mol/L sodium nitrite and incubated at room temperature. Af-
ter 15–25 min, mutagenesis was stopped by the addition of 5 mL of 0.5 
mol/L potassium phosphate buffer (pH 7.5). Mutated cells were diluted 
using 0.05 mol/L phosphate buffer (pH 7.5) to obtain 150–200 colo-
nies when 0.1 mL was spread on a YM agar plate. The YM agar plates 
were incubated at 30 °C until colonies were visible. The normal colony 
morphology on YM agar plates at 30 °C is a smooth, circular colony. 
The mutagenized colonies were examined for odd colony mor-
phologies. Cells from odd morphology colonies were transferred to 
both fresh YM agar and mGPP agar plates. The mGPP plates selected 
against auxotrophs. Isolates that formed colonies of similar size to the 
wild-type, grew in mGPP, and maintained their odd colony morphol-
ogy for at least 4 transfers on YM agar plates were saved for future 
study. The protocol for C. albicans CAI-4 was the same as for A72 ex-
cept that all media were supplemented with 40 mg/L uridine. 
Phase-contrast microscopy 
Cells from the isolate of interest were inoculated onto a YM agar plate 
and incubated at 28 °C for 5 d for A72 mutants or 7 d for CAI-4 mu-
tants. A longer incubation period was required for CAI-4 to compen-
sate for its slower growth rate. For smooth colonies, all visible cellu-
lar material from a 2.5 mm colony or a 2.5 × 2.5 mm section from a 
line inoculation was suspended in 1.0 mL of sterile 0.05 mol/L potas-
sium phosphate buffer (pH 6.5) and vortexed for 1 min to separate the 
cells. If the isolate of interest came from a colony whose texture was 
hard, indicating filaments only, or rubbery, indicating a high percent-
age of filaments, a 5-times larger area of cells was removed and ho-
mogenized using a sterile Pyrex hand homogenizer with 5 mL of phos-
phate buffer. Homogenization was necessary because in these cases 
vortexing did not result in individual cells. Cells were observed us-
ing a 40× phase-contrast lens on an Olympus BH2-RFCA microscope 
equipped with an Olympus C-2000 zoom digital camera (Olympus 
America Inc., Melville, N.Y.). 
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Farnesol-response assays 
YM agar plates were supplemented with 10, 50, or 100 μmol/L mixed 
isomer farnesol (Sigma, St. Louis, Mo.). A frozen stock of 100 mmol/L 
farnesol in ethanol was brought to room temperature and aliquoted 
into empty petri dishes. The liquid medium (55 °C) was added and 
the plates were swirled to mix. Line inoculations were used and plates 
were incubated at 28 °C for 5 or 7 d for A72 and CAI-4, respectively. 
For each isolate, the morphology of the streak was compared with a 
control plate with no added farnesol. Isolates were examined for any 
reduction in length or density of hairs and (or) reduction in wrinkles. 
Analysis of farnesol-production assays by gas chromatography 
and mass spectrometry (GC/MS) 
Cells were grown in mGPP at 30 °C. Extracellular farnesol from cell-
free supernatants was analyzed by GC/MS as described previously 
(Hornby et al. 2001; Hornby and Nickerson 2004). 
Results 
Isolation of C. albicans heritable colony morphological variants 
Candida albicans cells with a stable altered colony morphology were 
isolated following mutagenesis of 2 parent strains, A72 and CAI-4. 
These parental strains were chosen because they are well-character-
ized farnesol-producing and farnesol-responsive strains that have been 
previously used in in vitro studies (Hornby et al. 2001, 2003; Hornby 
and Nickerson 2004; Shchepin et al. 2003). 
EMS–UV mutagenesis 
For our first collection, cells were treated with EMS, followed by UV 
irradiation. One hundred thirty-four (0.1%) of the ca. 90 500 A72 sur-
vivors and 606 (0.6%) of the ca. 95 000 CAI-4 survivors had an odd 
colony morphology that was maintained following at least 4 transfers 
on YM or YEPD agar at 30 °C (Table 1). Under these conditions, unmu-
tagenized A72 and CAI-4 cells form smooth colonies with yeast cells 
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only (Figs. 1 and 2). The mutants fell into 7 distinct categories based 
on colony type: hairy, stippled, hairy stippled, wrinkled, hairy wrin-
kled, mountain-like, and shaggy dog. Representative mutants of each 
type are shown in Fig. 1. The majority of A72 mutants (96.3%) were in 
Table 1. Categories of colony morphology mutants obtained from C. albicans A72 and CAI-4. 
 A72   CAI-4 
Category  EMS–UV  EMS – nitrous acid  EMS–UV  EMS – nitrous acid 
Hairy 129 158 167 49 
Stippled 1 6 0 0 
Hairy stippled 1 25 0 12 
Wrinkled 0 5 1 3 
Hairy wrinkled 2 23 424 90 
Mountain-like 0 0 14 0 
Shaggy dog 1 0 0 0 
Total 134 217 606 154 
Note: Candida albicans cells were mutagenized by either EMS followed by UV irradiation or 
by EMS followed by nitrous acid application. Colonies with a stable altered morphology were 
selected on YM agar at 30 °C.   
Fig. 1. Representative examples of colony morphologies of parental strains and mu-
tants obtained in the screen. Candida albicans cells were plated on YM agar and in-
cubated for 5 d at 28 °C. Representative colony morphologies for (A) parental strain 
A72, (B) parental strain CAI-4, and mutants (C) shaggy dog, (D) hairy, (E) stippled, 
(F) wrinkled, (G) hairy stippled, (H) hairy wrinkled, and (I) mountain-like. The 
shaggy dog and mountain-like morphologies were unique for mutants of A72 and 
CAI-4, respectively. Mutants with the other mutant colony morphology types were 
recovered from both A72 and CAI-4.  
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Fig. 2. Examples of cell morphologies of parental strains and mutants obtained in 
the screen. (A) Parental strain A72 (average cell size 4 μm × 4.8 μm), (B) a hairy 
mutant (average mycelia width 2.5 μm) and (C) a shaggy dog mutant (average my-
celia width 3.5 μm).  
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the hairy category, whereas the majority of CAI-4 mutants (70%) were 
in the hairy wrinkled category. The second-highest number of CAI-4 
mutants (26.6%) was in the hairy category (Table 1). Each of these 
mutants was stable for ≥4 transfers and, for each mutant, a survey 
of a minimum of 1000 colonies showed uniform colony morphology. 
A clear relationship between C. albicans colony morphology and cell 
morphology has been well established (Radford et al. 1994). To confirm 
that colony morphology correlated with individual cell morphology, 
we examined a subset of the mutants grown at 28 °C by microscopy. 
This subset consisted of all 740 of the mutants generated by EMS–UV. 
Unmutagenized A72 and CAI-4 strains grew as yeasts only. Of the 740 
EMS–UV mutants described in Table 1, 1 A72 mutant in the shaggy dog 
category and 14 CAI-4 mutants in the mountain-like category grew as 
filaments only. The other 725 EMS/UV mutants all grew as a mixture 
of yeasts and filaments. Representative micrographs of the A72 parent 
strain and mutants are shown in Fig. 2. The variety of altered colony 
types is similar to those observed for phenotypic colony-type switch-
ing by Radford et al. (1994) and Perez-Martin et al. (1999). 
EMS – nitrous acid mutagenesis 
Low doses of UV irradiation (>90% survival) cause an increase in 
the frequency of colony-type switching in C. albicans (Slutsky et al. 
1985; Soll 1997). To reduce the possibility that some of the mutants 
we recovered in our screen were not actually mutants, but might in-
stead have resulted from exceptionally stable colony-type switching, 
we mutagenized A72 and CAI-4 with EMS, followed by nitrous acid. 
Currently, there is no reference for either EMS or nitrous acid induc-
ing phenotypic switching. In this screen, we found that 217 (0.3%) of 
the ca. 80 420 A72 survivors and 154 (0.2%) of ca. 75 000 CAI-4 sur-
vivors maintained odd colony morphology following ≥4 transfers on 
YM agar (Table 1). These mutants fell into 6 distinct categories based 
on colony morphology: hairy, stippled, hairy stippled, wrinkled, hairy 
wrinkled, and mountain-like. No shaggy dog mutants were isolated. 
Again, the majority of A72 mutants (72.8%) were in the hairy cat-
egory, whereas the majority of CAI-4 mutants (58.4%) were in the 
hairy wrinkled category with the second highest number (31.8%) in 
the hairy category. Thus, similar results were obtained when EMS was 
used in combination with either UV or nitrous acid. 
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Farnesol-responsive mutants 
All of the A72 and CAI-4 mutants (1111) were screened for their re-
sponsiveness to farnesol. They were tested on YM medium contain-
ing 0, 10, 50, and 100 μmol/L farnesol at 28 °C. It should be noted 
that for wild-type cells, 1– 2 μmol/L farnesol is sufficient to block the 
yeast to mycelial conversion (Mosel et al. 2005). A very high percent-
age of these mutants responded to farnesol addition by changing their 
colony morphology. On YM plates with farnesol, 191 (54.4%) of 351 
A72 mutants and 292 (38.4%) of 760 CAI-4 mutants fully reverted to 
wild-type morphology (Table 2) as judged by the formation of smooth 
and entire colonies (Fig. 3). Another group of mutants partially re-
verted in the presence of farnesol. In this group, which included 135 
(38.5%) of 351 A72 mutants and 448 (58.9%) of 760 CAI-4 mutants, 
farnesol reduced the wrinkled appearance in the center of the colony 
and shortened the hairs on the periphery, while simultaneously mak-
ing the hairs less dense (Fig. 3; Table 2). Thus, 326 (92.9%) of the A72 
mutants and 740 (97.4%) of the CAI-4 mutants responded to farnesol. 
These mutants were designated “farnesol responders”. Significantly, 
all farnesol responders exhibited a temporary or reversible response 
to farnesol. That is, they reverted towards wild-type colony morphol-
ogy on YM plus farnesol, but then regained their altered colony mor-
phology when restreaked on YM without farnesol. Microscopic exam-
ination of the responding mutants confirmed that colony morphology 
changes were accompanied by decreased filaments and an increased 
percentage of budding yeasts (data not shown). 
Table 2. Farnesol reversal of “mutant” colony phenotype. 
Category  A72  CAI-4 
Complete response  191  292 
Partial response  135  448 
No response  25  20 
Total  351  760 
Note: The effect of exogenous farnesol was measured by examining colony phenotype on YM 
agar containing 0 and 100 μmol/L farnesol at 28 °C. Mutants were categorized as “complete 
response” if they reverted to a wild-type phenotype (smooth and entire colonies) in the pres-
ence of 100 μmol/L farnesol. Mutants were categorized as “partial response” if the presence 
of 100 μmol/L farnesol caused a decrease in hair length, hair density, and (or) a decrease in 
wrinkling. Mutants were categorized as “no response” if farnesol caused no visible changes 
in colony morphology.   
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The remaining 25 (7.1%) of 351 A72 mutants and 20 (2.6%) of 760 
CAI-4 mutants did not respond to farnesol (Table 2) as judged by an 
unchanged colony morphology on YM plates with 100 μmol/L farne-
sol. These mutants were designated “farnesol non-responders”. The 
non-responding mutants did not exhibit decreased filamentation (data 
not shown). 
Farnesol production in 9 of the C. albicans colony morphology 
variants 
An attractive model suggests that mutants locked into the filamen-
tous mode either failed to synthesize farnesol or failed to respond to 
farnesol. To test this hypothesis, 4 mountain-like mutants (filamen-
tous only) and 5 hairy wrinkled mutants (yeast–filament mixtures) 
were analyzed for farnesol production by GC/MS (Table 3). These mu-
tants, chosen at random, were all derived from CAI-4. Farnesol pro-
duction in the CAI-4 parent was 0.11 ± 0.02 mg/g cells. All but 2 of the 
Fig. 3. Representative examples of mutants that revert to wild type (complete re-
sponse), partially revert (incomplete response), or show no change (no response) 
in the presence of farnesol. Candida albicans cells were plated on YM agar contain-
ing 0, 10, 50, or 100 μmol/L farnesol and incubated for 5 d at 28 °C.     
Jensen et  al .  in  Genome  49  (2006)       13
mutants produced extracellular farnesol at levels that were similar to 
or greater than the CAI-4 parent. H125, a mountain-like mutant, and 
H121, a hairy wrinkled mutant, did not produce detectable farnesol. 
Discussion 
We have characterized a collection of C. albicans mutants that are al-
tered in their colony morphology. One thousand one hundred eleven 
stable mutants with altered colony morphology were obtained and 
then tested for their response to farnesol. We found that farnesol-re-
sponsive mutants existed and were common. The majority of our mor-
phological mutants (92.9% of the A72 mutants and 97.4% of the CAI-4 
mutants) responded reversibly to farnesol. These mutants represent 
a novel collection of conditional morphological mutants. Presumably, 
the differences in farnesol responsiveness could result from partial 
loss-of-function mutations in 1 gene, mutations in several different 
genes, or activation and (or) induction of a second farnesol-response 
pathway that overrides the morphogenesis defect in the mutants. Be-
cause farnesol-responsive mutants are reversible and because they 
Table 3. Extracellular farnesol produced by parent strains and selected mutants derived from 
the CAI-4 parent. 
Category 
Strain  Colony morphology  Farnesol response  Farnesol concentration  
   (mg/g cell dry mass) 
CAI-4  Parent N/A  0.11 (±0.02)* 
H125  Mountain-like  Complete  Not detectable† 
H1  Mountain-like  Partial  0.10 
M3  Mountain-like  Partial  0.64 
H383  Mountain-like  Complete  0.29 
H152  Hairy wrinkled  Complete  0.09 
H68  Hairy wrinkled  Complete  0.14 
H253  Hairy winkled  Complete  0.62 
H88 Hairy wrinkled  Complete  0.46 
H121  Hairy wrinkled  Complete  Not detectable† 
Note: Mountain-like and hairy wrinkled mutants were randomly selected for analysis. 
* Twenty replicates were used to measure farnesol production in the CAI-4 parent strain. This 
value (0.11 mg/g cell dry mass) agrees nicely with that of (0.12 mg/g cell dry mass) previ-
ously reported based on 6 determinations (Hornby and Nickerson 2004). The amount of 
farnesol for the other samples is an average of duplicate samples that agree ±10%. 
† No farnesol was detected in 2 independent studies (detection limit of 0.005 mg/g).    
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are so common relative to mutants that fail to respond to farnesol, 
we think it is likely that farnesol activates and (or) induces a pathway 
that can override the morphogenesis defects in many of the farnesol-
responsive mutants. Candida albicans is a diploid fungus. In this re-
gard, the significance of farnesol remedial mutants does not depend 
on whether the mutants in our collection are: (i) altered in both cop-
ies of a gene, as was intended from the double mutagenesis protocols 
used (Kakar et al. 1983); (ii) single-copy haplo-insufficient mutants 
(Uhl et al. 2003); or (iii) exceptionally stable phenotypic switches. In 
each case, the reversal of the colony morphology phenotype by farne-
sol should be of interest. 
We expect many of the mutants in our collection to result from 
haplo-insufficiency. Uhl et al. (2003) used transposon mutagenesis to 
conduct a large-scale loss-of-function genetic screen for haplo-insuffi-
cient mutations that affect the switch between yeast and filamentous 
growth in C. albicans. They identified mutations in 146 genes from a 
library of 18 000 strains. This study was significant because they dem-
onstrated the utility of haplo-insufficiency for identifying mutations 
in genes affecting the morphogenic switch in C. albicans. We believe 
that many of our mutants may also be haplo-insufficient for the fol-
lowing reasons: (i) as Uhl et al. (2003) demonstrated, haplo-insuffi-
cient mutations affecting morphogenesis are common; (ii) we recov-
ered morphological mutants at frequencies of 0.1% for A72 and 0.6% 
for CAI-4, values similar to the frequency of morphological mutants 
in the Uhl et al. (2003) screen (0.08%); and (iii) we recovered the 7 
categories of morphological mutants at similar frequencies after treat-
ment with different combinations of mutagens (Table 1). 
Some of our mutants may also result from colony-type switching. 
Candida albicans can spontaneously and reversibly switch between at 
least 7 general phenotypes that can be seen by changes in colony mor-
phology, a form of phenotypic switching (Slutsky et al. 1985). Sponta-
neous colony variants of C. albicans 3153A occur at a frequency of 1.4 
× 10–4 (0.01%). The phenotype of the colony variants is heritable, be-
cause the phenotypes persist through several clonal platings, with the 
caveat that these variants themselves have a high rate of secondary 
spontaneous switching. For example, colony variants of 3153A have 
secondary switching frequencies of 4.9 × 10–2 (4.9%). Low doses of 
UV light (>90% survival) increase phenotypic switching in C. albicans 
3153A by a factor of approximately 200 (Slutsky et al. 1985). Again, 
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the UV-treated 3153A colony variants have a high secondary- switch-
ing frequency (2.5 × 10–2 or 2.5%). Our screen also recovered high-
frequency switchers, but we did not keep them. Instead, the mutants 
described herein were selected to give a low secondary-switching fre-
quency and were distinct from high-frequency switchers in 3 ways: (i) 
many of our mutants were originally isolated in 2001 and their mor-
phological phenotype has been maintained through greater than 10 
transfers; (ii) for each mutant, a survey of a minimum of 1000 colo-
nies showed uniform colony morphology; and (iii) all of our farnesol 
responders were reversible; they returned to the altered colony mor-
phology when farnesol was removed. Thus, although some of our mu-
tants might have resulted from a colony-type switch, that switch must 
be exceptionally stable. 
Here we have shown that farnesol-responsive mutants are common. 
Candida albicans is normally able to respond to 1–2 μmol/L farne-
sol. These farnesol-responsive mutants may require exogenous farne-
sol either because their response to farnesol is attenuated such that 
they do not respond to the concentrations of farnesol normally en-
countered in colonies or because high concentrations of farnesol hy-
peractivates a second, dominant mechanism that inhibits filamenta-
tion by overriding the morphogenesis defect of the mutants. Another 
example in which farnesol exhibited an overriding control on cellu-
lar physiology is provided by Granshaw et al. (2003). In Neurospora 
crassa, circadian rhythms can be seen as a series of bands or conid-
iation regions on the surface of agar media. Mutations in 3 different 
genes (frq, wc-1, and wc-2) led to loss of circadian rhythm. However, 
addition of farnesol or geraniol (10–100 μmol/L) restored rhythmic 
banding to strains lacking a circadian rhythm owing to mutations in 
any 1 of these 3 genes. Granshaw et al. (2003) interpreted their data 
in terms of a two-oscillator model in which farnesol activated or am-
plified the remaining oscillator. 
Mutants that fail to make detectable farnesol could have a defect in 
farnesol synthesis or they could hyperactivate a farnesol-degradation 
or -conversion pathway. Further analysis will be necessary to distin-
guish between these possibilities. Farnesol is synthesized from farne-
syl pyrophosphate, an intermediate in the highly conserved sterol bio-
synthetic pathway (Hornby et al. 2003). An in vitro assay has been 
developed for farnesol synthesis from farnesyl pyrophosphate (Hornby 
et al. 2003) and we are currently using it to purify and identify the 
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proteins responsible for farnesol biosynthesis. Mutants that fail to 
make farnesol will be useful in complementation studies, i.e., do the 
genes identified by the reverse biochemical approach actually comple-
ment the mutations? This will be an important confirmation that the 
correct gene or genes have been cloned and a test for whether or not 
we have identified all of the genes for farnesol biosynthesis. 
Mutants that do not respond to farnesol may be lacking a critical 
farnesol receptor, a signal transduction pathway activated by farne-
sol, or have mutations in a morphogenic pathway that overrides the 
farnesol response. For instance, some of these mutants could be de-
fective in CHK1 function (Kruppa et al. 2004). Chk1p is a histidine ki-
nase that functions in a two-component signal transduction pathway 
and C. albicans strains lacking both copies of CHK1 do not respond to 
farnesol (Kruppa et al. 2004). It may be possible to identify the miss-
ing proteins in the mutants by comparing the pattern of proteins from 
wild-type and mutant C. albicans on two-dimensional gels. 
We observed differences in the frequencies of mutants in distinct 
morphological categories for A72 versus CAI-4. The majority of A72 
mutants (96.3%) were in the hairy category, whereas there were 2 
major categories for the CAI-4 mutants (70% were hairy wrinkled and 
26.6% were hairy; Table 1). These differences may reflect genetic dif-
ferences between the strains. For instance, CAI-4 might be heterozy-
gous for a recessive mutation that results in formation of hairy wrin-
kled colonies, whereas A72 is wild type for both alleles. If so, mutants 
with a hairy wrinkled phenotype would be recovered more frequently 
from CAI-4. Similarly, differences in the genetic backgrounds of A72 
and CAI-4 might explain the apparent dichotomy leading to shaggy 
dog colonies in mutants of A72 and mountain-like colonies in mutants 
of CAI-4. Alternatively, this colony difference could be a further man-
ifestation of the iro-1 defect in CAI-4 (Garcia et al. 2001).  
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